期刊
BONE MARROW TRANSPLANTATION
卷 25, 期 2, 页码 217-218出版社
STOCKTON PRESS
DOI: 10.1038/sj.bmt.1702102
关键词
hypereosinophilic syndrome; allogeneic peripheral blood stem cell transplantation; myelofibrosis
Patients with hypereosinophilic syndrome (HES) display a very heterogeneous clinical picture ranging from asymptomatic cases to very aggressive forms. We report a 38-year-old woman with progressive HES who developed severe myelofibrosis and was treated by allogeneic stem cell transplantation, using peripheral blood (PBSCT) instead of bone marrow as the source of progenitor cells, after conditioning with cytoxan and busulphan, To the best of our knowledge, this is the first case of HES with myelofibrosis treated with PBSCT, The patient remains alive 8 months post-PBSCT, and bone marrow fibrosis has significantly decreased following transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据